Corporate Update – Opus Genetics
Market Activity (24‑hour period ending 01:18 AM CET, Friday 23 Feb 2026)
- Opus Genetics (ticker IRD) increased by 2.74 %.
- Current trading price: USD 3.82 per share on major exchanges.
- Shares outstanding: 83.2 million.
- Market capitalization: USD 333.6 million.
- Volume traded in the last 24 hours: USD 5.6 million.
- Since the end of the previous month, the share price has fallen by 20.16 %.
- 200‑day simple moving average: USD 4.13.
- 52‑week high: USD 7.07 (9 Sep 2026).
- 52‑week low: USD 1.70 (18 Nov 2025).
Comparative Performance (24‑hour period)
| Company | Ticker | Change | Current Price (USD) | Market Capitalization (USD mn) |
|---|---|---|---|---|
| Vista Gold | VGZ | +1.84 % | 2.63 | 397 |
| Starz Entertainment | STRZ | +5.24 % | 23.22 | 398.7 |
| General Fusion | GFUZ | –0.16 % | 6.18 | 398.5 |
| Alpha Teknova | TKNO | –20.84 % | 6.15 | 396.8 |
| Community Health | CYH | –1.05 % | 2.91 | 397.6 |
Additional data: Community Health has a price‑earnings ratio of 1.55.
Corporate Profile – Opus Genetics
Opus Genetics (formerly Ocuphire Pharma, Inc.) is a clinical‑stage ophthalmic biopharmaceutical company. The firm focuses on developing and commercializing therapies for various eye disorders. Its headquarters are located in Farmington Hills, United States. Opus Genetics is listed on the Nasdaq stock exchange and serves a global customer base through its official website, www.ocuphire.com .
